Appointment Follows Israeli Ministry of Health Approval for Nexalin’s Gen-2 SYNC Device… HOUSTON, TX, Nov. 13, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company”...
Appointment Follows Israeli Ministry of Health Approval for Nexalin’s Gen-2 SYNC Device… HOUSTON, TX, Nov. 13, 2025 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company”...